ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

BRMP Investigators Find New Lung Tumor Antigen, Seek Developers

January 8, 1982

Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting

November 22, 2013

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000